Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Booster Dose of H5N1 Influenza Vaccine in Adults and Elderly
NCT00561184Phase 2Completed
- Sponsor
- Novartis
- Start
- Oct 2007
- Primary completion
- Dec 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of inactivated Vero cell based whole virus influenza A/H5N1 in Avian Influenza (AI) (2 arms), sponsored by Novartis. Primary endpoints: Number and percentage of subjects with at least one local reaction and Number and percentage of subjects with at least one systemic reaction. Started Oct 2007; status: completed.
02
Drugs
inactivated Vero cell based whole virus influenza A/H5N1
03
Conditions
Avian Influenza (AI)
Beyond the preview
Go deeper on NCT00561184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00561184.